ViraDx™ - Rapid Point-of-Care Test for SARS-CoV-2, Flu A and Flu B
1 Sample - 3 Results
ViraDx™ is a point-of-care test to detect and differentiate SARS-CoV-2, Flu A and Flu B from one sample.
Product Features
EFFICIENT: 3 results to aid in a differential diagnosis at the point of care
RAPID: actionable results in 15 minutes to help improve patient management decisions
HIGHLY CORRELATED TO PCR*:
COVID-19: Sensitivity (Anterior nasal swab) 93.8%; Specificity 100%
COVID-19: Sensitivity (Nasopharyngeal) 93.1%; Specificity 100%
Flu A: Sensitivity 92.2%; Specificity 94.2%
Flu B: Sensitivity 90.0%; Specificity 94.3%
INSTRUMENT-FREE: user-friendly test procedure for non-lab settings
*ViraDx [package insert] PM-169.2 Carlsbad, CA: Lumos Diagnostics; 2023.
For in vitro diagnostic use
For Rx Use Only
ViraDx Emergency Use Authorization Number (EUA): EUA220131